ALLINAIRE THERAPEUTICS
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. The technology is based on the discovery by scientific founders Irina Petrache, MD, and Matthias Clauss, Ph.D. of a novel therapeutic target that plays a central role in the development and progression of lung disease.
ALLINAIRE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.allinaire.com
Total Employee:
11+
Status:
Active
Contact:
+1 216-455-3200
Email Addresses:
[email protected]
Total Funding:
1.57 M USD
Technology used in webpage:
Viewport Meta SPF Google Font API Content Delivery Network LetsEncrypt SSL By Default HSTS Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioCrossroads
BioCrossroads investment in Seed Round - Allinaire Therapeutics
IU Ventures
IU Ventures investment in Seed Round - Allinaire Therapeutics
BioMotiv
BioMotiv investment in Seed Round - Allinaire Therapeutics
Official Site Inspections
http://www.allinaire.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Allinaire Therapeutics"
Allinaire Therapeutics - Crunchbase Company Profile & Funding
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. The technology is based on the discovery by …See details»
Allinaire Therapeutics 2025 Company Profile: Valuation, Funding ...
Allinaire Therapeutics General Information Description. Operator of a biotechnology company intended to develop novel therapeutics for cardiopulmonary diseases. The company develops …See details»
Allinaire Therapeutics, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Allinaire Therapeutics, LLC of Cleveland, OH. Get the latest business insights from Dun & Bradstreet.See details»
Allinaire Therapeutics Company Profile - Craft
Allinaire Therapeutics is a company that develops treatments for chronic obstructive pulmonary disease and other pulmonary diseases. It leverages technology based on a therapeutic target …See details»
Allinaire Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Research growth is mainly driven by partnerships and collaborations (Allinaire Therapeutics, Aptar Digital health, Kaia Health) and acquisitions (Amryt). In 2022, Chiesi also …See details»
Allinaire Therapeutics - The Org
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.See details»
Allinaire Therapeutics LLC - Company Profile and News
Company profile page for Allinaire Therapeutics LLC including stock price, company news, executives, board members, and contact informationSee details»
Allinaire Therapeutics - Overview, News & Similar companies
Who is Allinaire Therapeutics. Allinaire Therapeutics aims to develop novel therapeutics for COPD and other pulmonary diseases. The technology is based on the discovery by the sc ientific …See details»
Home — Allinaire Therapeutics
Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, OH 44106. [email protected] ...See details»
Allinaire Therapeutics - VentureRadar
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. The technology is based on the discovery by …See details»
Allinaire Therapeutics, LLC Overview - SignalHire
Allinaire Therapeutics, LLC is a private company that has been in the industry for 8 years. The company currently specializes in the Research area. ... Organization Website: allinaire.com : …See details»
Allinaire Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 27, 2017: Seed Round - …See details»
Leadership Overview — Allinaire Therapeutics
Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, OH 44106. [email protected] ...See details»
Developing Novel Antibodies: Stories: More IU Research: Research …
Jul 6, 2022 Allinaire’s technology is built upon the research of its two scientific founders, Matthias Clauss, a senior research professor at the IU School of Medicine, and Dr. Irina …See details»
Overview - Allinaire Therapeutics
Allinaire was founded in 2016 by BioMotiv (www.biomotiv.com; now managed by Advent Life Sciences, www.adventls.com), with the licensed technology from Indiana University. EMAP II …See details»
Allinaire Therapeutics - Contacts, Employees, Board Members, …
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.See details»
Leadership - Allinaire Therapeutics
Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, OH 44106. [email protected] . This folder does not contain any pages. Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, …See details»
Allinaire Therapeutics - Tech Stack, Apps, Patents & Trademarks
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. New. Resources. ... Log In. Experience the …See details»
Douglas W.P. Hay, PhD — Allinaire Therapeutics
Allinaire Therapeutics 11000 Cedar Ave #18 Cleveland, OH 44106. [email protected] ...See details»
Outgoing OC Transpo GM to head up Quebec infrastructure agency
18 hours ago Outgoing OC Transpo general manager Renée Amilcar has been named the first president and CEO of a new agency in Quebec.See details»